Big Pharma companies in China are looking for growth in 2016 to rise up to the challenges to the industry's approach to sales and marketing. The paradigm shift constitutes companies to provide products and services to improve the health of patients whilst clearly demonstrating value for money.
"As most companies in China relies and has established placement in the core market, it is an opportunity to expand to broader markets by replying on sales representatives to seek prospects and to organise off-site events to gain access into the locality market" (Catherine Yu, Marketing Director, Merck Serono) in describing growth opportunities in the Chinese market. Hear from major practitioners in Marcus Evan's upcoming 4th Annual Pharma 2016: Sales & Marketing Excellence Forum scheduled on the 24th - 25th November 2016 in InterContinental Hotel Shanghai Pudong, China.
Top speakers include Frank Wang (Vice President of Commercial Operation, Takeda), Joseph Jia (Vice President/Business Unit Head, Shanghai CP Guojian Pharmaceutical), Victoire Maugis de Lajudie (Director, Customer Innovation, Sanofi), William Liang (Vice President, Oncology Business Unit, AstraZeneca) and Timothy White (Global Head of Customer Experience, Teva Pharmaceuticals, Netherlands).
One of the highlights of this forum is the way Pharma companies reengineer their business growth strategies to expand to broad markets; cultivate modern sales force with smarter marketing techniques and technology; and keeping mature brands alive in the every changing Pharma environment. This forum is also proud to present the Gold Sponsor from QuintilesIMS, Aktana and i-Click Interactive Asia Limited; Business Development Sponsor from Ryan Partners Business Consulting and Exhibition Sponsor from Veeva Systems.